Senling Feng

836 total citations
28 papers, 651 citations indexed

About

Senling Feng is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Senling Feng has authored 28 papers receiving a total of 651 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 12 papers in Pharmacology and 8 papers in Oncology. Recurrent topics in Senling Feng's work include Drug Transport and Resistance Mechanisms (5 papers), Liver Disease Diagnosis and Treatment (5 papers) and Ferroptosis and cancer prognosis (5 papers). Senling Feng is often cited by papers focused on Drug Transport and Resistance Mechanisms (5 papers), Liver Disease Diagnosis and Treatment (5 papers) and Ferroptosis and cancer prognosis (5 papers). Senling Feng collaborates with scholars based in China and Macao. Senling Feng's co-authors include Ying Xie, Zhongwen Yuan, Wenzhe Ma, Liang Liu, Hua Zhou, Xiaojun Yao, Jiajun Huang, Wanjun Lin, Zhongqiu Liu and Wenting Zhu and has published in prestigious journals such as Scientific Reports, European Journal of Pharmacology and Clinica Chimica Acta.

In The Last Decade

Senling Feng

27 papers receiving 641 citations

Peers

Senling Feng

PHARM

ONCOL

PRM

Shian‐Ren Lin Taiwan

Cunsi Shen China

Peifen Yao Macao

Kesavan Sabitha India

Kyoo Seok Ahn South Korea

Jochen Rutz Germany

Kader Turkekul Türkiye

Martin Jozef Péč Slovakia

Julia Kin-Ming Lee Hong Kong

Simiao Fan China

Shian‐Ren Lin Taiwan

Senling Feng

399 ×1.1

114 ×0.9

PHARM

130 ×1.1

ONCOL

107 ×0.9

85 ×0.8

PRM

Citations per year, relative to Senling Feng Senling Feng (= 1×) peers Shian‐Ren Lin

Countries citing papers authored by Senling Feng

Since Specialization

Citations

This map shows the geographic impact of Senling Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Senling Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Senling Feng more than expected).

Fields of papers citing papers by Senling Feng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Senling Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Senling Feng. The network helps show where Senling Feng may publish in the future.

Co-authorship network of co-authors of Senling Feng

This figure shows the co-authorship network connecting the top 25 collaborators of Senling Feng. A scholar is included among the top collaborators of Senling Feng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Senling Feng. Senling Feng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dai, Ling, Yanfang Guo, Liang Zhong, et al.. (2025). An integrin-based quercetin 7-rhamnoside liver-targeted delivery liposomes for intrahepatic cholestasis in pregnancy. Materials Today Bio. 33. 102031–102031.

Duan, Yingying, Jiaqi Tian, Yuqin Yin, et al.. (2025). Elucidation of the mechanism Underlying the promotion of ferroptosis and enhanced antitumor immunity by citrus polymethoxyflavones in CRC cells. Frontiers in Pharmacology. 16. 1571178–1571178. 2 indexed citations

Zhu, Wenting, et al.. (2025). A Progesterone Microneedle Patch for Self-Administration in the Prevention of Preterm Birth in a Mouse Model. Drug Design Development and Therapy. Volume 19. 2473–2490. 1 indexed citations

Hong, Ye, et al.. (2024). Fisetin exerts neuroprotective effects in vivo and in vitro by inhibiting ferroptosis and oxidative stress after traumatic brain injury. Frontiers in Pharmacology. 15. 1480345–1480345. 13 indexed citations

Duan, Yingying, et al.. (2024). The superiority of PMFs on reversing drug resistance of colon cancer and the effect on aerobic glycolysis-ROS-autophagy signaling axis. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 32(12). 1891–1902. 2 indexed citations

Feng, Senling, Yuting Li, Hongliang Huang, et al.. (2023). Isoorientin reverses lung cancer drug resistance by promoting ferroptosis via the SIRT6/Nrf2/GPX4 signaling pathway. European Journal of Pharmacology. 954. 175853–175853. 34 indexed citations

Feng, Senling, et al.. (2023). Isoquercitrin attenuates the progression of non-alcoholic steatohepatitis in mice by modulating galectin-3-mediated insulin resistance and lipid metabolism. Phytomedicine. 123. 155188–155188. 15 indexed citations

Huang, Hongliang, Yingying Duan, Zhongwen Yuan, et al.. (2022). Effective prediction of potential ferroptosis critical genes in clinical colorectal cancer. Frontiers in Oncology. 12. 1033044–1033044. 11 indexed citations

Xie, Ying, Senling Feng, Fang He, et al.. (2022). Down-regulating Nrf2 by tangeretin reverses multiple drug resistance to both chemotherapy and EGFR tyrosine kinase inhibitors in lung cancer. Pharmacological Research. 186. 106514–106514. 23 indexed citations

10.

Xie, Ying, Chu-Tian Mai, De-Chong Zheng, et al.. (2021). Wutou decoction ameliorates experimental rheumatoid arthritis via regulating NF-kB and Nrf2: Integrating efficacy-oriented compatibility of traditional Chinese medicine. Phytomedicine. 85. 153522–153522. 50 indexed citations

11.

Zhang, Jing, et al.. (2021). Evaluation of lipid metabolism imbalance in HIV-infected patients with metabolic disorders using high-performance liquid chromatography-tandem mass spectrometry. Clinica Chimica Acta. 526. 30–42. 4 indexed citations

12.

Wang, Zhongping, Wenting Zhu, Zhongwen Yuan, et al.. (2021). Development of a novel ssDNA aptamer targeting cardiac troponin I and its clinical applications. Analytical and Bioanalytical Chemistry. 413(28). 7043–7053. 14 indexed citations

13.

Liu, Rui-Ming, Peng Xu, Qi Chen, Senling Feng, & Ying Xie. (2020). A multiple-targets alkaloid nuciferine overcomes paclitaxel-induced drug resistance in vitro and in vivo. Phytomedicine. 79. 153342–153342. 37 indexed citations

14.

Xie, Ying, Senling Feng, Chu-Tian Mai, et al.. (2020). Suppression of up-regulated LXRα by silybin ameliorates experimental rheumatoid arthritis and abnormal lipid metabolism. Phytomedicine. 80. 153339–153339. 25 indexed citations

15.

Feng, Senling, Deyan Wu, De-Chong Zheng, et al.. (2019). Nobiletin and its derivatives overcome multidrug resistance (MDR) in cancer: total synthesis and discovery of potent MDR reversal agents. Acta Pharmaceutica Sinica B. 10(2). 327–343. 48 indexed citations

16.

Lin, Wanjun, Jiajun Huang, Zhongwen Yuan, et al.. (2017). Protein kinase C inhibitor chelerythrine selectively inhibits proliferation of triple-negative breast cancer cells. Scientific Reports. 7(1). 2022–2022. 60 indexed citations

17.

Yuan, Zhongwen, Yazhuo Li, Zhongqiu Liu, et al.. (2017). Role of tangeretin as a potential bioavailability enhancer for silybin: Pharmacokinetic and pharmacological studies. Pharmacological Research. 128. 153–166. 46 indexed citations

18.

Feng, Senling, Zhongwen Yuan, Xiaojun Yao, et al.. (2016). Tangeretin, a citrus pentamethoxyflavone, antagonizes ABCB1-mediated multidrug resistance by inhibiting its transport function. Pharmacological Research. 110. 193–204. 34 indexed citations

19.

Lin, Wanjun, Jiajun Huang, Zhongwen Yuan, et al.. (2016). Neo-tanshinlactone selectively inhibits the proliferation of estrogen receptor positive breast cancer cells through transcriptional down-regulation of estrogen receptor alpha. Pharmacological Research. 111. 849–858. 29 indexed citations

20.

Ma, Wenzhe, Senling Feng, Xiaojun Yao, et al.. (2015). Nobiletin enhances the efficacy of chemotherapeutic agents in ABCB1 overexpression cancer cells. Scientific Reports. 5(1). 18789–18789. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact